vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and PLAYSTUDIOS, Inc. (MYPS). Click either name above to swap in a different company.
PLAYSTUDIOS, Inc. is the larger business by last-quarter revenue ($55.4M vs $43.6M, roughly 1.3× GRAIL, Inc.). PLAYSTUDIOS, Inc. runs the higher net margin — -24.7% vs -227.5%, a 202.8% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs -18.3%). PLAYSTUDIOS, Inc. produced more free cash flow last quarter ($3.6M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs -15.6%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
GRAL vs MYPS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $55.4M |
| Net Profit | $-99.2M | $-13.7M |
| Gross Margin | — | — |
| Operating Margin | -285.4% | -17.7% |
| Net Margin | -227.5% | -24.7% |
| Revenue YoY | 14.0% | -18.3% |
| Net Profit YoY | -2.2% | 38.9% |
| EPS (diluted) | $-2.37 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $55.4M | ||
| Q3 25 | $36.2M | $57.6M | ||
| Q2 25 | $35.5M | $59.3M | ||
| Q1 25 | $31.8M | $62.7M | ||
| Q4 24 | $38.3M | $67.8M | ||
| Q3 24 | $28.7M | $71.2M | ||
| Q2 24 | $32.0M | $72.6M | ||
| Q1 24 | $26.7M | $77.8M |
| Q4 25 | $-99.2M | $-13.7M | ||
| Q3 25 | $-89.0M | $-9.1M | ||
| Q2 25 | $-114.0M | $-2.9M | ||
| Q1 25 | $-106.2M | $-2.9M | ||
| Q4 24 | $-97.1M | $-22.4M | ||
| Q3 24 | $-125.7M | $-3.1M | ||
| Q2 24 | $-1.6B | $-2.6M | ||
| Q1 24 | $-218.9M | $-567.0K |
| Q4 25 | -285.4% | -17.7% | ||
| Q3 25 | -346.2% | -13.6% | ||
| Q2 25 | -446.9% | -5.9% | ||
| Q1 25 | -482.5% | -4.4% | ||
| Q4 24 | -358.0% | -33.1% | ||
| Q3 24 | -640.5% | -6.7% | ||
| Q2 24 | -5133.8% | -5.5% | ||
| Q1 24 | -851.1% | -2.2% |
| Q4 25 | -227.5% | -24.7% | ||
| Q3 25 | -245.8% | -15.8% | ||
| Q2 25 | -320.7% | -5.0% | ||
| Q1 25 | -333.6% | -4.6% | ||
| Q4 24 | -253.8% | -33.1% | ||
| Q3 24 | -438.7% | -4.3% | ||
| Q2 24 | -4958.8% | -3.6% | ||
| Q1 24 | -819.3% | -0.7% |
| Q4 25 | $-2.37 | $-0.12 | ||
| Q3 25 | $-2.46 | $-0.07 | ||
| Q2 25 | $-3.18 | $-0.02 | ||
| Q1 25 | $-3.10 | $-0.02 | ||
| Q4 24 | $-1.49 | $-0.18 | ||
| Q3 24 | $-3.94 | $-0.02 | ||
| Q2 24 | $-51.06 | $-0.02 | ||
| Q1 24 | $-7.05 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | $104.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $227.9M |
| Total Assets | $2.9B | $290.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | $104.9M | ||
| Q3 25 | $126.9M | $106.3M | ||
| Q2 25 | $127.4M | $112.9M | ||
| Q1 25 | $133.9M | $107.1M | ||
| Q4 24 | $214.2M | $109.2M | ||
| Q3 24 | $853.6M | $105.2M | ||
| Q2 24 | $958.8M | $106.3M | ||
| Q1 24 | $199.7M | $127.0M |
| Q4 25 | $2.6B | $227.9M | ||
| Q3 25 | $2.2B | $238.9M | ||
| Q2 25 | $2.3B | $245.3M | ||
| Q1 25 | $2.4B | $244.1M | ||
| Q4 24 | $2.5B | $244.7M | ||
| Q3 24 | $2.6B | $265.2M | ||
| Q2 24 | $2.7B | $263.6M | ||
| Q1 24 | — | $288.4M |
| Q4 25 | $2.9B | $290.6M | ||
| Q3 25 | $2.6B | $299.2M | ||
| Q2 25 | $2.7B | $316.2M | ||
| Q1 25 | $2.8B | $313.8M | ||
| Q4 24 | $3.0B | $323.0M | ||
| Q3 24 | $3.1B | $330.6M | ||
| Q2 24 | $3.3B | $333.4M | ||
| Q1 24 | — | $357.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $3.7M |
| Free Cash FlowOCF − Capex | $-63.9M | $3.6M |
| FCF MarginFCF / Revenue | -146.5% | 6.5% |
| Capex IntensityCapex / Revenue | 0.2% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $25.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $3.7M | ||
| Q3 25 | $-63.2M | $5.7M | ||
| Q2 25 | $-77.0M | $13.6M | ||
| Q1 25 | $-95.0M | $3.3M | ||
| Q4 24 | — | $11.6M | ||
| Q3 24 | $-104.6M | $14.6M | ||
| Q2 24 | $-171.8M | $14.5M | ||
| Q1 24 | $-207.3M | $5.0M |
| Q4 25 | $-63.9M | $3.6M | ||
| Q3 25 | $-63.6M | $5.4M | ||
| Q2 25 | $-77.3M | $13.2M | ||
| Q1 25 | $-95.1M | $3.2M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | $-105.6M | $13.9M | ||
| Q2 24 | $-173.2M | $12.8M | ||
| Q1 24 | $-209.8M | $3.6M |
| Q4 25 | -146.5% | 6.5% | ||
| Q3 25 | -175.8% | 9.3% | ||
| Q2 25 | -217.6% | 22.3% | ||
| Q1 25 | -298.6% | 5.1% | ||
| Q4 24 | — | 16.9% | ||
| Q3 24 | -368.4% | 19.6% | ||
| Q2 24 | -541.7% | 17.6% | ||
| Q1 24 | -785.3% | 4.6% |
| Q4 25 | 0.2% | 0.2% | ||
| Q3 25 | 1.1% | 0.5% | ||
| Q2 25 | 1.0% | 0.7% | ||
| Q1 25 | 0.2% | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 3.4% | 0.9% | ||
| Q2 24 | 4.3% | 2.4% | ||
| Q1 24 | 9.5% | 1.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
MYPS
Segment breakdown not available.
